A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Milton S. Hershey Medical Center
Y-mAbs Therapeutics
National Cancer Institute (NCI)
City of Hope Medical Center
Bristol-Myers Squibb
Stanford University
University of Louisville
National Cancer Institute (NCI)